Pipeline Report

Updated February 1st, 2026

BuyandBill.com Analytics Pro Features

Unlock Full Access to
BuyandBill.com Analytics

Upgrade to BuyandBill.com Pro to access this report and the complete suite of analytics tools.

You attempted to open: Drug Pipeline Report
10+ Years of Historical Pricing Data
Unlimited Access to All Drug Pages
Comparative & Historical Drug Pricing Reports
PriceDoctoRx Self-Administered Drug Pricing
Medicare & Medicaid Claims Data
Drug Pipeline Report
Check Out New Features
Comparative Pricing Reports

Search

Descriptive Alt Text

Filters

Showing results 2,729–2,736 of 4,419
Manufacturer ▼ Drug Name Indication Stage Status Route of Administration Drug Class
Merck & Company Inc. IO102-IO103 with pembrolizumab - (basket trial) Metastatic solid tumors Phase 2 Enrollment Conclusion Intravenous Oncology
Merck & Company Inc. MK-8507-013 and Islatravir - (IMAGINE-DR) HIV Phase 2 Oral Anti-HIV
Merck & Company Inc. ALX148 and KEYTRUDA (pembrolizumab) - (ASPEN-04) Head and Neck Squamous Cell Carcinoma Phase 2 Data Released Intravenous Oncology
Merck & Company Inc. Bomedemstat and ruxolitinib Myelofibrosis Phase 2 Ongoing Oral Hematology
Merck & Company Inc. Bomedemstat Polycythemia Vera Phase 2 Enrollment Initiation Oral Hematology
Merck & Company Inc. Bomedemstat (IMG-7289) Myelofibrosis Phase 2 Trial Completed Oral Hematology
Merck & Company Inc. Tulisokibart (PRA023) - (ARTEMIS-UC) Ulcerative colitis Phase 2 Data Released Intravenous Gastroenterology
Merck & Company Inc. Ensifentrine (RPL554) COVID-19 Phase 2 Trial Discontinued Inhalation COVID-19